Importance of Open Lung Biopsy in the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies
|
|
- Madeleine Berniece Fields
- 5 years ago
- Views:
Transcription
1 American Journal of Hematology 71:75 79 (2002) Importance of Open Lung Biopsy in the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies Kihyun Kim, 1 Mark H. Lee, 1 * Jingook Kim, 2 Kyung Soo Lee, 3 Sung Min Kim, 1 Man Pyo Jung, 1 Joungho Han, 4 Ki Woong Sung, 5 Won Seog Kim, 1 Chul Won Jung, 1 Sung Soo Yoon, 1 Young-Hyuck Im, 1 Won Ki Kang, 1 Keunchil Park, 1 and Chan Hyung Park 1 1 Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea 2 Department of Thoracic Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea 3 Department of Radiology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea 4 Department of Diagnostic Pathology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea 5 Department of Pediatrics, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea Invasive pulmonary aspergillosis is a serious infectious complication in immunocompromised patients. Recent reports indicate its favorable clinical outcomes by early diagnosis with chest computed tomography scan. We retrospectively analyzed our experiences with histopathological evaluation by open lung biopsy in 31 patients (32 cases) with hematologic malignancies, suspected of having invasive pulmonary aspergillosis clinically and radiologically. Although the initial computed tomography findings of all cases were highly indicative of invasive pulmonary aspergillosis by demonstrating nodules or masses with a halo sign (16 cases), segmental area of consolidation with ground-glass attenuation (7 cases), both nodules or masses with a halo sign and segmental areaof consolidation with ground-glass attenuation (7 cases) and poorly defined centrilobular nodules (2 cases), we could histopathologically confirm invasive fungal infections only in 17 cases (53.1%) by open lung biopsy. There were 13 cases of invasive pulmonary aspergillosis, two cases of aspergilloma, and two cases of mucormycosis. No fungal hyphae were found in the other 15 cases: organizing pneumonia in seven cases, pulmonary hemorrhage in three cases, brochiolitis obliterans with organizing pneumonia in two cases, and CMV pneumonia, pulmonary tuberculosis, candida pneumonia in one case each, respectively. We could perform open lung biopsy without mortality and significant morbidity. In view of the low positive predictive value of chest computed tomography scan and the very low morbidity of open lung biopsy, this procedure is recommendable for the diagnosis of invasive pulmonary aspergillosis and determination of its treatment. Am. J. Hematol. 71:75 79, Wiley-Liss, Inc. Key words: aspergillosis; open lung biopsy; computed tomography INTRODUCTION Invasive pulmonary aspergillosis (IPA) is a serious infectious complication in patients with hematologic malignancies. The incidence of aspergillosis is increasing due to widespread use of intensive chemotherapy and immunosuppressive agents and due to increasing numbers of organ transplantations and AIDS patients [1]. The mortality rate of IPA in patients with neutropenia resulting from chemotherapy for leukemia was %, and moreover, it reached up to % in bone marrow transplantation (BMT) patients in recent reports of metaanalysis [2,3] Wiley-Liss, Inc. Recently, there are several studies indicating that early detection of IPA with computed tomography (CT) scan and aggressive medical treatment in combination with surgery improved the survival in these patients [4 9]. *Correspondence to: Mark H. Lee, M.D., Division of Hematology- Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 50 Ilwon-Dong, Kangnam-Ku, Seoul , Korea. mlee@smc.samsung.co.kr Received for publication 15 March 2002; Accepted 15 May 2002 Published online in Wiley InterScience ( com). DOI: /ajh.10168
2 76 Kim et al. A halo sign on the CT scan, nodule surrounded by an area of ground-glass attenuation, is an important indicator for diagnosing IPA in neutropenic patients and it appears during the early stage of IPA [10,11]. Aircrescent sign is also a key indicator of IPA but less useful for early diagnosis as it usually appears with bone marrow recovery [12]. Although some surgical series reported a high positive predictive value of CT scan in the diagnosis of IPA [4 9], a preliminary study from our center showed a low positive predictive value [13]. Here, we evaluated our further experiences with histopathological confirmation by open lung biopsy in patients suspected of IPA on thin-sectioned CT scan. PATIENTS AND METHODS Patients Between May 1995 and January 2001, 325 patients with hematologic malignancies including severe aplastic anemia were treated in our institution. Among them, 74 and 54 patients underwent allogeneic BMT and autologous peripheral blood stem cell transplantation (PBSCT), respectively. Chest CT scans for the evaluation of lung infiltrates during the period of neutropenic fever or post- BMT immunosuppression were performed for 114 patients. The primary radiologic diagnoses were as follows: IPA for 51 patients (52 cases), bacterial pneumonia for 22 patients, cytomegalovirus (CMV) or Pneumocystis carinii pneumonia for 19 patients, brochiolitis obliterans with organizing pneumonia (BOOP) for 7 patients, pulmonary tuberculosis for 7 patients, and other diagnoses for 8 patients. Among 51 patients with hematologic malignancies suspected of having IPA on thin-sectioned CT scan, open lung biopsy was performed for 31 patients (32 cases) to confirm the diagnosis. Two separate episodes occurred in one patient at a 7-month interval, and biopsies were done at each time. The reasons why open lung biopsy was not performed for the other 20 patients were as follows: 7 expired before biopsy due to underlying disease progression or other causes, 6 were medically treated without pathological confirmation according to the attending physicians preference, 3 refused open lung biopsy, 2 developed Aspergillus rhinosinusitis simultaneously, and Aspergillus species were detected in sputum culture for other 2 patients. All patients were nursed in the hematology-oncology wards of Samsung Medical Center built in October The wards had ducted ventilation facilities with a ventilating fan producing positive air flow to each room. The volume of air ventilating each room per hour was 3 times as much as the volume of the room, and the air ventilating the room was exhausted without further circulation. The air pressure among the rooms was equal. The inflow air was filtered twice by dust filter. The elimination efficiency of dust in the atmosphere by dust filters was 90% or more. There was extension work, which could provoke an epidemic of IPA, done to the main building adjacent to the wards from July 1997 through October Diagnosis and Treatment Strategy When a febrile neutropenic episode occurred in patients with hematologic malignancies, broad-spectrum antibiotics (usually -lactam plus aminoglycoside) were administered intravenously as an empirical treatment. Severe neutropenia was defined as absolute neutrophil count (ANC) less than 500/mm 3. If fever persisted for 48 hrs or more, vancomycin was added intravenously. Amphotericin B was added empirically (0.5 mg/kg/day) when fever persisted for another 48-hr period after the beginning of vancomycin. When pulmonic lesions on chest roentgenogram showed no improvements with empirical antibiotics or if pulmonary fungal infections were radiologically suspected, a chest high-resolution CT (HRCT) scan was planned. CT scan technique used has been previously described (1-mm thin section at 10-mm interval during full inspiration) [13]. On CT scan, nodules or masses with halo sign, air-crescent sign, and consolidation with ground-glass attenuation were considered to be lesions indicative of IPA. Once HRCT scan revealed findings consistent with IPA, the dose of amphotericin B was increased to mg/kg/day. A thoracotomy or a video-assisted thoracoscopic surgery was performed when feasible, depending on the patient s clinical situation for pathological diagnosis. Although open lung biopsy was primarily planned for pathological diagnosis, complete resection was done if possible. Sputum panculture and smear were done in all the patients, but a bronchoscopy with bronchoalveolar lavage (BAL) was not routinely planned. In addition to routine hematoxylin and eosin (H&E) staining on the surgical specimens, para-aminosalicylic acid (PAS) and methenamine silver staining were done to detect fungal hyphae, and fungus culture was done for all surgical specimens. Statistical Analysis The positive predictive value of CT scan was calculated by the percentage of IPA cases including aspergilloma and mucormycosis confirmed by histopathology divided by total open lung biopsy cases. The patient characteristics and clinical findings between group A and group B were compared by Fisher s exact test and Mann Whitney test. Prognostic factors associated with clinical outcome were analyzed by Fisher s exact test, and survival curves were plotted according to the Kaplan Meier method.
3 Open Lung Biopsy for Invasive Pulmonary Aspergillosis 77 TABLE I. Patient Characteristics a RESULTS Patient Characteristics Among 51 patients with hematologic malignancies suspected of having IPA on thin-sectioned CT scan, open lung biopsy was performed for 31 patients (32 cases) to confirm the diagnosis as described. Among those undergoing open lung biopsy, 16 patients (17 cases) were confirmed to have invasive pulmonary fungal infection. Patient characteristics of the histopathologically confirmed invasive pulmonary fungal infection cases (group A) and the false-positive cases (group B) which were indicative of IPA on HRCT but histologically negative for IPA, were detailed in Table I. There was no statistically significant difference between the two groups (P > 0.05). Among 63 patients whose primary radiologic diagnoses were not IPA, three subsequently developed pulmonic fungal infection. Two of them were diagnosed to have Aspergillus and mucormycosis tracheobronchitis by endobronchial biopsy of their pseudomembrane during brochoscopy. Brochoscopy was performed 15 and 58 days after the initial CT scans due to persistence of centrilobular nodules on follow-up CT scans in both cases. The third case in immunosuppression due to chronic GVHD was radiologically diagnosed to have pulmonary tuberculosis by CT scan but proved to be chronic IPA after fine-needle aspiration of the lung lesion, which was performed 3 days after the CT scan. Clinical and Radiological Features Group A (N 17) b Group B (N 15) Age (years, range) 40 (14 58) 35 (22 58) Male/Female 12/5 12/3 Diagnosis Acute leukemia NHL 1 1 CML 1 MDS 1 1 Treatment Chemotherapy Allo-BMT 3 2 Steroid (>1 mg/kg/day) 4 2 Duration of Neutropenia (days, range) 24 (0 43) 18 (0 59) a Group A, histologically confirmed IPA cases; Group B, false-positive group (the cases indicative of IPA on HRCT but histopathologically negative for IPA). Abbreviations: NHL, non-hodgkin lymphoma; CML, chronic myeloid leukemia; MDS, myelodysplastic syndromes; allo-bmt, allogeneic bone marrow transplantation. b A patient who has had two episodes was counted twice. The most common initial symptoms were fever and cough. Blood-tinged sputum and pleuritic chest pain were more common in group A than in group B without statistical significance (8 and 9 cases vs. both 3 cases, P and 0.076). The median duration from the initial symptom to the radiologic diagnosis was 12 days in group A and 7 days in group B. At the time of the radiological diagnosis, 10 cases in group A and 12 cases in group B had severe neutropenia. The median duration from severe neutropenia to the radiologic diagnosis was 16 days (range, 0 36) in group A and 11 days (range, 0 30) for group B. Median values of fibrinogen in group A and B were 5.63 g/l (range, ) and 5.52 g/l (range, ), respectively, without significant difference (P 0.90). The initial CT findings of 17 cases in group A were as follows: (i) nodules or masses with halo sign in 9 cases; (ii) segmental area of consolidation with ground-glass attenuation in 4 cases; (iii) both segmental area of consolidation with ground-glass attenuation and nodules or masses with a halo sign in 2 cases; and (iv) poorly defined centrilobular nodules in 2 cases (Fig. 1). Those of 15 cases in group B were as follows: (i) nodules or masses with a halo sign in 7 cases; (ii) segmental area of consolidation with ground-glass attenuation in 3 cases; and (iii) both segmental area of consolidation with ground-glass attenuation and nodules or masses with a halo sign in 5 cases. In group A, 11 cases showed multiple lesions and 6 cases showed single lesions. In group B, 11 and 2 cases demonstrated multiple lesions and single lesions, respectively. Cavitary lesions were detected from the follow-up CT scans in 3 cases in group A and 1 case in group B. These radiological findings were not statistically different between the two groups (P > 0.05). Open Lung Biopsy and Histopathologic Findings Open lung biopsies were done in the 32 cases on 31 patients. Three of them were video-assisted thoracic surgery (VATS). The timing of open lung biopsy was dependent on the patient s condition. There was no emergency case for the treatment of hemoptysis. Although surgical procedures were primarily performed for pathological diagnosis, complete resection of fungal lesion was possible in 6 of the 8 cases with single lesions. Except for 1 case of lobectomy, most of the surgical procedures were segmental or subsegmental wedge resections. The interval from the radiologic diagnosis to the surgery was 9 days (range, 1 37) in group A and 12 days (range, 1 29) in group B (P > 0.05). Open lung biopsies were done during severe neutropenic status (ANC < 500/ mm 3 ) in 9 cases and severe thrombocytopenia (platelet count <20,000/mm 3 ) in 2 cases with platelet transfusion. The median amount of transfused packed red blood cells and platelets concentrate was 1 pint (range, 0 6) and 12 units (range, 0 40), respectively. Most of the complications were minor problems such as pain and minor
4 78 Kim et al. Fig. 1. Initial CT findings that suggest invasive pulmonary aspergillosis: (left) nodule with halo sign; (middle) segmental area of consolidation with groundglass attenuation; and (right) poorly defined centrilobular nodule. All of these lesions were histopathologically proven to be invasive aspergillosis. wound problems; however, one patient experienced cardiac arrest with subsequent acute renal failure on the day of the surgery but recovered fully without any sequelae. Only one case of Aspergillus flavus was found in sputum pan-culture, which was done in all the patients. Fungal hyphae were found in 17 of the 32 cases, and the histopathologic diagnoses were as follows (group A): IPA in 13 cases, aspergilloma in 2 cases, and invasive pulmonary mucormycosis in 2 cases. From the cultures of surgical specimens, 1 case of Aspergillus fumigatus and 1 case of Aspergillus species were obtained. On the contrary, we could not find any fungal hyphae in the other 15 cases, and their histopathologic diagnoses were as follows (group B): organizing pneumonia in 7 cases, pulmonary hemorrhage in 3 cases, BOOP in 2 cases, and CMV pneumonia, pulmonary tuberculosis, and candida pneumonia (neutrophilic abscess with yeast) in one case each, respectively. Thus the positive predictive value of chest HRCT scan in the diagnosis of fungal infections was 53.1% in this study. In addition, brochoscopy with BAL fluid analysis including cytology, mycoscopy, and fungus culture was done in eight of 51 patients radiologically suspected of having IPA; however, none of 8 showed the evidence of fungal infection. DISCUSSION As Aspergillus is ubiquitous in the air and environment, isolation with high-efficiency particulate air filtration or laminar air flow has been the only way to reduce the risk of aspergillosis [1]. Itraconazole prophylaxis has been eagerly tried, but erratic absorption of oral form has limited its routine use. Although itraconazole solution with better pharmacokinetic profile was reported effective for aspergillosis prophylaxis, it has not yet been firmly established [14]. At the present day, early diagnosis with aggressive treatment is the best way to reduce mortality [1]. IPA is suspected when fever persists with pulmonary infiltrates in immunocompromised patients in spite of the administration of broad-spectrum antibiotics. If nodules with halo sign or air-crescent sign can be detected, the possibility of IPA becomes even higher. The strategy for early detection of IPA using chest CT scan has been tried successfully [12]. The standard treatment of IPA has been the administration of amphotericin B with or without itraconazole. Several recent studies of surgical approaches in combination with medical treatment were encouraging in selective cases with favorable results [4 9]. Although no randomized prospective study has been reported, they suggested that surgical approach could be helpful in certain circumstances. In these reports, excluding emergency operation for massive hemoptysis, the objectives of surgery were mainly for either resection of the localized masses to prevent massive pulmonary hemorrhage that might be fatal or eradication of residual fungal foci prior to further cytotoxic chemotherapy or BMT. These surgical series reported favorable results with minor surgical complications in spite of neutropenia or thrombocytopenia in these patients. In these reports the histopathologic diagnosis revealed a high positive predictive value of chest CT scan ranging from 81.5% to 100% to confirm the preoperative diagnosis. On the contrary, our previously published data reporting a positive predictive value of 58.3% [13] were so different from those of other studies that we pursued a new strategy to confirm the histopathologic diagnosis for all patients with suspected IPA. We performed open lung biopsy in 32 cases on 31 patients who were clinically and radiologically indicative of having IPA. In this study only 17 of the 32 cases (53.1%, 95% confidence interval %) had IPA including two cases with mucormycosis, essentially identical to our previous rate of 58.3%. Although this study is small in terms of patient size, our cases are less selective than those of other surgical series in which most of the enrolled patients were
5 Open Lung Biopsy for Invasive Pulmonary Aspergillosis 79 selected not for diagnostic purposes but for therapeutic purposes. Although open lung biopsies were done during severe neutropenic status and severe thrombocytopenia, no serious complication occurred in our study. Open lung biopsy is a safe and tolerable procedure in the diagnosis of IPA. Earlier histopathologic confirmation by open lung biopsy is important in determining whether patients continue to be treated, especially when we keep in mind the high toxicity profile of amphotericin B for patients who are scheduled for further cytotoxic chemotherapy or BMT in the future. Although open lung biopsy was safely performed in our study, more convenient diagnostic methods for IPA should be explored. As described in other reports [1,4], fever, pleuritic chest pain, and hemoptysis were common symptoms for IPA patients and there was a trend for higher incidences of pleuritic chest pain in patients with IPA compared to patients without IPA (P 0.076). Sputum smear and culture are neither sensitive nor specific, and serum antigenemia test has a low sensitivity [15]. Fibrinogen level was correlated with diagnosis and prognosis in a study, but we could not confirm the results [4]. Although we did not perform bronchoscopy with BAL routinely as it has variable sensitivity but a high specificity, recent reports showed that antigenemia test with BAL fluid could enhance the sensitivity [4,15]. CTguided percutaneous fine needle aspiration and biopsy can be a useful diagnostic method for peripheral lesions but it can hardly be performed for central lesions or for patients with severe thrombocytopenia or coagulopathy [16,17]. Recently new techniques based on PCR or sandwich ELISA for the detection of antigen such as Aspergillus galactomannan has been reported and would be helpful [15,18 20]. In conclusion, in view of low positive predictive value of chest CT scan and very low morbidity of open lung biopsy, this procedure is recommendable for the diagnosis of IPA and determination of its treatment. REFERENCES 1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26: Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23: Lin S-J, Schranz J, Teutsch SM. Aspergillosis case fatality rate: systemic review of the literature. Clin Infect Dis 2001;32: Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;5: Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH, Lampe FC, Gillespie S. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis 2000;31: Wong K, Waters CM, Walesby RK. Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. Eur J Cardiothorac Surg 1992;6: Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schlapfer R, Stulz P, Perruchoud AP, Tichelli A, Gratwohl A, Tamm M. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998;158: Salerno CT, Ouyang DW, Pederson TS, Larson DM, Shake JP, Johnson EM, Maddaus MA. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 1998;65: Pidhorecky I, Urschel J, Anderson T. Resection of invasive pulmonary aspergillosis in immunocompromised patients. Ann Surg Oncol 2000; 7: Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157: Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, Lopez J, Couillault G, Piard F, Vagner O, Guy H. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001;19: Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994;106: Won HJ, Lee KS, Cheon JE, Hwang JH, Kim TS, Lee HG, Han J. Invasive pulmonary aspergillosis: prediction at thin-section CT in patients with neutropenia: a prospective study. Radiology 1998;208: Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW on behalf of the U.K. Multicentre Antifungal Prophylaxis Study Group. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. Br J Hematol 1999;105: Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12: Hwang S, Kim H, Park S, Jung J, Jang H. The value of CT-guided percutaneous needle aspiration in immunocompromised patients with suspected pulmonary infection. Am J Radiol 2000;175: Denining D, Evans E, Kibbler C, Richardson M, Roberts M, Rogers T, Warnock D, Warren R. Guidelines for the investigation of invasive fungal infection in hematologic malignancy and solid organ transplantation. Eur J Clin Microbiol Infect Dis 1997;16: Hebart H, Loffler J, Meisner C, Serey F, Schimid D, Bohme A, Martin H, Engel A, Bunjes D, Kern WV, Schumacher U, Kanz L, Einsele H. Early detection of Aspergillus infection after allogenic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000; 181: Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenverghe P, Van Eldere J, Verbist L, Boogaerts M. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by sandwich enzyme-linked immunosorbent assay for hematologic patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neuropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:
Invasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationSurgical Therapy for Pulmonary Aspergillosis in Immunocompromised Patients
Surgical Therapy for Pulmonary Aspergillosis in Immunocompromised Patients Christopher T. Salerno, MD, David W. Ouyang, BS, Timothy S. Pederson, BA, David M. Larson, MD, Jay P. Shake, MD, Eric M. Johnson,
More informationLung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases
Lung Resection for Invasive Pulmonary Aspergillosis in Neutropenic Patients with Hematologic Diseases FRANK REICHENBERGER, JAMES HABICHT, ACHIM KAIM, PETER DALQUEN, FRANZISKA BERNET, REINHARD SCHLÄPFER,
More informationIndre Vengalyte MD¹, Regina Pileckyte MD¹, Laimonas Griskevicius MD PhD 1, 2
ASPERGILLUS GALACTOMANNAN (GM) ANTIGEN IN THE BRONCHOALVEOLAR LAVAGE (BAL) FLUID FOR THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS (IPA) IN HEMATOLOGICAL PATIENTS Indre Vengalyte MD¹, Regina Pileckyte
More informationThe prognosis of invasive pulmonary aspergillosis
Surgical Management of Invasive Pulmonary Aspergillosis in Neutropenic s Alain Bernard, MD, Denis Caillot, MD, Jean François Couaillier, MD, Olivier Casasnovas, MD, Henri Guy, MD, and Jean Pierre Favre,
More information2046: Fungal Infection Pre-Infusion Data
2046: Fungal Infection Pre-Infusion Data Fungal infections are significant opportunistic infections affecting transplant patients. Because these infections are quite serious, it is important to collect
More informationASPERGILLOSIS IN THE NON-NEUTROPENIC HOST
ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST Dr J Garbino University Hospital Geneva ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST INTRODUCTION SWISS ASPERGILLOSIS SURVEY IN THE NON-NEUTROPENIC HOST Introduction
More informationamphotericin B empiric therapy; preemptive therapy presumptive therapy Preemptive therapy Presumptive therapy ET targeted therapy ET
4 17 9 27 17 1 7 amphotericin B 34 empiric therapy; ET preemptive therapy presumptive therapy Preemptive therapy Presumptive therapy ET targeted therapy ET Key words: antifungal therapyempiric therapypreemptive
More informationTREATMENT STRATEGIES FOR INVASIVE FUNGAL INFECTIONS. Part I: EMPIRICAL THERAPY
TREATMENT STRATEGIES FOR INVASIVE FUNGAL INFECTIONS Part I: EMPIRICAL THERAPY CAUSES OF DEATH IN PATIENTS WITH MALIGNANCIES NIJMEGEN, THE NETHERLANDS n = 328 BACTERIAL INFECTION FUNGAL INFECTION 7% 36%
More informationSurgical indications: Non-malignant pulmonary diseases. Punnarerk Thongcharoen
Surgical indications: Non-malignant pulmonary diseases Punnarerk Thongcharoen Non-malignant Malignant as a pathological term: Cancer Non-malignant = not cancer Malignant as an adjective: Disposed to cause
More informationECMM Excellence Centers Quality Audit
ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected
More informationIs pre-emptive therapy a realistic approach?
Is pre-emptive therapy a realistic approach? J Peter Donnelly PhD, FRCPath Department of Haematology Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands Is pre-emptive therapy a realistic
More informationPROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino
PROGRESSI NELLA TERAPIA ANTIFUNGINA A tribute to Piero Martino 1946-2007 ITALIAN ICONS IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI 1961 CAUSES OF DEATH IN PATIENTS WITH MALIGNANCIES
More informationTIMM 2013 Role of non-culture biomarkers for detection of fungal infections
TIMM 2013 Role of non-culture biomarkers for detection of fungal infections Tom Rogers Clinical Microbiology, Trinity College Dublin Tom Rogers, TCD & St James s Hospital Dublin, Ireland FACTORS INFLUENCING
More informationCLINICAL PATTERNS AMONG INVASIVE PULMONARY ASPERGILLOSIS PATIENTS WITH AND WITHOUT RECENT INTENSIVE IMMUNOSUPPRESSIVE THERAPY
CLINICAL PATTERNS AMONG INVASIVE PULMONARY ASPERGILLOSIS PATIENTS WITH AND WITHOUT RECENT INTENSIVE IMMUNOSUPPRESSIVE THERAPY Gee-Chen Chang, 1,2 Kai-Ming Chang, 1,2 Chieh-Liang Wu, 1 and Chi-Der Chiang
More informationReverse Halo Sign in Pulmonary Mucormyosis
QJM Advance Access published February 6, 2014 Reverse Halo Sign in Pulmonary Mucormyosis Yu-Hsiang Juan MD 1,2, Sachin S Saboo, MD FRCR 1, Yu-Ching Lin MD 2, James R. Conner MD, Ph.D 3, Francine L. Jacobson
More informationPneumothorax: A Rare Presentation of. Pulmonary Mycetoma. Prem Parkash Gupta* Sanjay Fotedar* Dipti Agarwal** Kuldeep Saini* Sarita Magu***
Pneumothorax: A Rare Presentation of Pulmonary Mycetoma Prem Parkash Gupta* Sanjay Fotedar* Dipti Agarwal** Kuldeep Saini* Sarita Magu*** Departments of *Respiratory Medicine, **Physiology, and ***Radiodiagnosis,
More informationPulmonary Aspergillosis
May 2005 Pulmonary Aspergillosis Nancy Wei, Harvard Medical School, Year III Overview Pulmonary aspergillosis background information Patient presentations Common radiographic findings for each type of
More informationMAJOR ARTICLE. Correlation of GM and Lung Infiltrates CID 2005:41 (15 October) 1143
MAJOR ARTICLE Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies M. Weisser, 1 C. Rausch,
More informationT he presence of invasive filamentous fungal infections
Infectious Disorders research paper Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies ANNAMARIA NOSARI, MICHELA ANGHILIERI, GIANPAOLO CARRAFIELLO,
More informationProphylaxis, Empirical, Pre-emptive Therapy of Aspergillosis in Hematological Patients: Which Strategy?
TIMM-4 18-21 October 2009 Athens, Greece Prophylaxis, Empirical, Pre-emptive Therapy of Aspergillosis in Hematological Patients: Which Strategy? www.ichs.org Georg Maschmeyer Dept. of Hematology, Oncology
More informationMANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS
MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According
More informationRisks and outcome of fungal infection in neutropenic children with hematologic diseases
The Turkish Journal of Pediatrics 2010; 52: 121-125 Original Risks and outcome of fungal infection in neutropenic children with hematologic diseases Selin Aytaç 1, İnci Yıldırım², Mehmet Ceyhan², Mualla
More informationDiagnostic Procedures for Pulmonary Infiltrates in the Compromised Host
Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host Michael Douvas, MD Heme/Onc Gerald Donowitz, MD - ID Eric Davis, MD - Pulmonary Disclosure Drs. Davis, Donowitz, and Douvas do not
More informationControversies in management: prophylaxis or diagnostics
5 th Advances Against Aspergillosis Controversies in management: prophylaxis or diagnostics Caveats in the use of biological markers for early diagnosis Drosos E. Karageorgopoulos, MD Researcher, Alfa
More informationF O R THE PAST 30 years, increasing doses of chemotherapeutic
Improved Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients Using Early Thoracic Computed Tomographic Scan and Surgery By Denis Caillot, Olivier Casasnovas, Alain Bernard, Jean-Francois
More informationImmunocompromised patients. Immunocompromised patients. Immunocompromised patients
Value of CT in Early Pneumonia in Immunocompromised Patients Nantaka Kiranantawat, PSU Preventative Factors Phagocyts Cellular immunity Humoral immunity Predisposing Factors Infection, Stress, Poor nutrition,
More informationProphylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong
Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases Y.L. Kwong Department of Medicine University of Hong Kong Pathogenic yeast Candida Cryptococcus Trichosporon Pathogenic
More informationThin-Section CT Findings in 32 Immunocompromised Patients with Cytomegalovirus Pneumonia Who Do Not Have AIDS
Tomás Franquet 1,2 Kyung S. Lee 3 Nestor L. Müller 1 Received January 27, 2003; accepted after revision April 21, 2003. 1 Department of Radiology, Vancouver Hospital and Health Sciences Center and University
More informationHAEMATOLOGY ANTIFUNGAL POLICY
HAEMATOLOGY ANTIFUNGAL POLICY PROPHYLAXIS Primary Prophylaxis Patient Group Patients receiving intensive remissioninduction chemotherapy for Acute Leukaemia (excluding patients receiving vinca alkaloids)
More informationSuccessful treatment of larynxtracheobronchial-pulmonary
Case Report Successful treatment of larynxtracheobronchial-pulmonary aspergillosis in an immunocompetent host W.X. Qu, X.W. Feng and L. Zhao The First Respiratory Department of Shengjing Hospital, China
More informationCase Studies in Fungal Infections and Antifungal Therapy
Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry
More informationThe Utility of Surgical Lung Biopsy in Immunocompromised Children
The Utility of Surgical Lung Biopsy in Immunocompromised Children Jessica A. Naiditch, MD, Katherine A. Barsness, MD, and David H. Rothstein, MD Objective To determine the utility of lung biopsy in immunocompromised
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationAspergillus species. The clinical spectrum of pulmonary aspergillosis
Pentalfa 3 maart 2016 The clinical spectrum of pulmonary aspergillosis Pascal Van Bleyenbergh, Pneumologie UZ Leuven Aspergillus species First described in 1729 * >250 species * ubiquitous Inhalation of
More informationTOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR
TOWARDS PRE-EMPTIVE? GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% TRADITIONAL DIAGNOSIS β-d-glucan Neg Predict Value 100% PCR diagnostics FUNGAL BURDEN FIRST TEST POSITIVE FOR ASPERGILLOSIS
More informationPrimary prophylaxis of invasive fungal infection in patients with haematological diseases
Primary prophylaxis of invasive fungal infection in patients with haematological diseases Tunis, May 24 2012 Important questions for antifungal prophylaxis Who are the patients at risk? Which is the risk:
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationMonitorization, Separation and Quantification of Antifungals used for Invasive Aspergillosis Treatment by High Performance Thin Layer Chromatography
Monitorization, Separation and Quantification of Antifungals used for Invasive Aspergillosis Treatment by High Performance Thin Layer Chromatography M. P. Domingo, M. Vidal, J. Pardo, A. Rezusta, L. Roc,
More informationFungal Infections in Neutropenic Hematological Disorders
Fungal Infections in Neutropenic Hematological Disorders 23 Dr Farah Jijina 24 Fungal Infections in Neutropenic Hematological Disorders 25 Dr Farah Jijina 26 Fungal Infections in Neutropenic Hematological
More informationMay-Lin Wilgus. A. Study Purpose and Rationale
Utility of a Computer-Aided Diagnosis Program in the Evaluation of Solitary Pulmonary Nodules Detected on Computed Tomography Scans: A Prospective Observational Study May-Lin Wilgus A. Study Purpose and
More informationComplications after HSCT. ICU Fellowship Training Radboudumc
Complications after HSCT ICU Fellowship Training Radboudumc Type of HSCT HSCT Improved outcome due to better HLA matching, conditioning regimens, post transplant supportive care Over one-third have pulmonary
More informationThe Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale
The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant
More informationESCMID Online Lecture Library. by author. Salvage Therapy of Invasive Aspergillosis Refractory to Primary Treatment with Voriconazole
Salvage Therapy of Invasive Aspergillosis Refractory to Primary Treatment with Voriconazole J.A. Maertens, hematologist, MD, PhD University Hospital Gasthuisberg Leuven, Belgium Current guidelines: first-line
More informationNeutropenic patients are at high risk of developing
Surgical Management of Invasive Pulmonary Fungal Infection in Hematology Patients Sanjay Theodore, MCh, Matthew Liava a, MBChB, Phillip Antippa, FRACS, Rochelle Wynne, PhD, Andrew Grigg, FRACP, Monica
More informationESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel
CASE PRESENTATION ECCMID clinical grand round May 2014 Anat Stern, MD Rambam medical center Haifa, Israel An 18 years old Female, from Ukraine, diagnosed with acute lymphoblastic leukemia (ALL) in 2003.
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationPAGL Inclusion Approved at January 2017 PGC
Guideline for the prophylaxis and treatment of fungal infections in Haematology patients 1. Introduction PAGL Inclusion Approved at January 2017 PGC Haematology, CHUGGS June 2016 This guideline sets out
More informationSevere Viral Related Complications Following Allo-HCT for Severe Aplastic Anemia
Severe Viral Related Complications Following Allo-HCT for Severe Aplastic Anemia Liat Shragian Alon, MD Rabin Medical Center, ISRAEL #EBMT15 www.ebmt.org Patient: 25-year-old male No prior medical history
More informationOpen Forum Infectious Diseases Advance Access published February 11, 2016
Open Forum Infectious Diseases Advance Access published February 11, 2016 1 A Critical Reappraisal of Prolonged Neutropenia as a Risk Factor for Invasive Pulmonary Aspergillosis Michael S. Abers 1,2, Musie
More informationDepartment of Pediatric Hematology/Oncology, University Children s Hospital Tübingen, Hoppe-Seyler-Strß 1, Tübingen, Germany 2
Case Reports in Transplantation Volume 2012, Article ID 672923, 4 pages doi:10.1155/2012/672923 Case Report Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem
More informationFungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center
Fungal Infections: Management and Reporting Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center February 25, 2010 Objectives Review common fungal infections in HCT patients Review current available
More informationEMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS DR LOW CHIAN YONG MBBS, MRCP(UK), MMed(Int Med), FAMS Consultant, Dept of Infectious Diseases, SGH Introduction The incidence of invasive fungal
More informationWHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?
WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,
More informationAspergillosis in the critically ill patient
Aspergillosis in the critically ill patient José Artur Paiva Director of Emergency and Intensive Care Department Centro Hospitalar São João Porto Associate Professor of Medicine University of Porto Infection
More informationMAJOR ARTICLE. Outcomes of Patients with IA and AML-MDS CID 2008:47 (15 December) 1507
MAJOR ARTICLE Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study Lennert
More informationPulmonary Nodular Lesions in Bone Marrow Transplant Recipients Impact of Histologic Diagnosis on Patient Management and Prognosis
Anatomic Pathology / PULMONARY NODULAR LESIONS IN BONE MARROW TRANSPLANT RECIPIENTS Pulmonary Nodular Lesions in Bone Marrow Transplant Recipients Impact of Histologic Diagnosis on Patient Management and
More informationInvasive Aspergillosis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Analysis
BJID 2008; 12 (October) 385 Invasive Aspergillosis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Analysis Viviane Maria Hessel Carvalho-Dias 1, Caroline Bonamin Santos Sola 1, Clóvis
More informationWhen is failure failure?
When is failure failure? Bart-Jan Kullberg, M.D. Radboud University Nijmegen The Netherlands The ICU patient with candidemia!! Female, 39 years old!! Multiple abdominal surgeries for Crohn's disease!!
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationAntifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary
Antifungal Agents - Cresemba (isavuconazonium), Noxafil (posaconazole), Vfend (voriconazole) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2,14 Drug FDA Indication(s) Dosing Cresemba
More informationECMO in oncology and immunosupressed patients. Peter Schellongowski Department of Medicine I Intensive Care Unit 13.i2 Medical University of Vienna
ECMO in oncology and immunosupressed patients Peter Schellongowski Department of Medicine I Intensive Care Unit 13.i2 Medical University of Vienna ECMO in immunocompromised patients? Is it feasible? Is
More informationManagement Strategies For Invasive Mycoses: An MD Anderson Perspective
Management Strategies For Invasive Mycoses: An MD Anderson Perspective Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA Professor of Medicine Director of Mycology Research Program M. D. Anderson Cancer
More informationOutcomes of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2011, p. 4613 4618 Vol. 55, No. 10 0066-4804/11/$12.00 doi:10.1128/aac.00669-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Outcomes
More informationManagement of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma
ORIGINAL ARTICLE Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Jhingook Kim, MD, PhD,* Young Mog Shim, MD,
More informationOutline NEW DIAGNOSTIC TOOLS WHY? WHICH TESTS? WHEN TO USE THEM? Documented IFI
New Developments and Challenges in Diagnostics of Invasive Fungal Infections O. Marchetti, MD Infectious Diseases Service, Department of Medicine, CHUV and University of Lausanne, Switzerland Workshop
More informationPatients with hematologic malignant diseases necessitating
AGGRESSIVE SURGICAL MANAGEMENT IN LOCALIZED PULMONARY MYCOTIC AND NONMYCOTIC INFECTIONS FOR NEUTROPENIC PATIENTS WITH ACUTE LEUKEMIA: REPORT OF EIGHTEEN CASES O. Baron, MD a B. Guillaumé, MD b P. Moreau,
More informationLung Injury after HCT
Lung Injury after HCT J. Douglas Rizzo, MD, MS Financial Disclosure None SCS06_1.ppt Background HCT an important therapeutic modality for malignant and non-malignant diseases Pulmonary Toxicity common
More informationInvasive Aspergillosis in India: Unique Challenges. Dr Rajeev Soman Consultant Physician PD Hinduja Hospital Mumbai
Invasive Aspergillosis in India: Unique Challenges Dr Rajeev Soman Consultant Physician PD Hinduja Hospital Mumbai Aspergillus Challenges Capable of surviving & thriving in all the diverse environmental
More informationDr. Arghya Samanta PG-3 Department of Pediatrics
Dr. Arghya Samanta PG-3 Department of Pediatrics A 3 year old male K/C/O B-cell Acute lymphoblastic leukemia Undergoing induction phase of chemotherapy On day 23 of induction Presented with - high grade
More informationTop 5 papers in clinical mycology
Top 5 papers in clinical mycology Dirk Vogelaers Department of General Internal Medicine University Hospital Ghent Joint symposium BVIKM/BSIMC and SBMHA/BVMDM Influenza-associated aspergillosis in critically
More informationItraconazole vs. fluconazole for antifungal prophylaxis in allogeneic stem-cell transplant patients D. J. Winston
REVIEW Itraconazole vs. fluconazole for antifungal prophylaxis in allogeneic stem-cell transplant patients D. J. Winston Division of Hematology-Oncology, Department of Medicine, UCLA Medical Center, Los
More information23/08/2015. What are we going to discuss here today? Legionella. Can dust and water harm you? Legionella Aspergillus
Can dust and water harm you? Carol Robinson CNM3 Infection Prevention and Control SIVUH What are we going to discuss here today? Legionella Aspergillus Some bacteria not covered are Pseudomonas spp, Cryptosporidiosis,
More informationChronic pulmonary aspergillosis diagnosis and management in resource-limited setting
Chronic pulmonary aspergillosis diagnosis and management in resource-limited setting Professor Retno Wahyuningsih Professor of Medical Mycology Department of Parasitology, Faculty of Medicine Universitas
More informationUse of Antifungal Drugs in the Year 2006"
Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine
More informationCultivated anti-aspergillus T H 1 Cells. Thomas Lehrnbecher Pediatric Hematology and Oncology Frankfurt/Main, Germany
Cultivated anti-aspergillus T H 1 Cells Thomas Lehrnbecher Pediatric Hematology and Oncology Frankfurt/Main, Germany Invasive fungal infection after allogeneic SCT Incidence of proven invasive fungal infections
More informationRole of HRCT in detection and characterization of pulmonary abnormalities in patients with febrile neutropenia
Original Article Role of HRCT in detection and characterization of pulmonary abnormalities in patients with febrile neutropenia Mandeep Kang, Debasis Deoghuria, Subash Varma 1, Dheeraj Gupta 2, Anmol Bhatia,
More informationValue of Bronchoalveolar Lavage Fluid Cytology in the Diagnosis of Pneumocystis jirovecii Pneumonia: A Review of 30 Cases
http://dx.doi.org/10.4046/trd.2011.71.5.322 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2011;71:322-327 CopyrightC2011. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationHow Can We Prevent Invasive Fungal Disease?
How Can We Prevent Invasive Fungal Disease? Chris Kibbler Professor of Medical Microbiology University College London And Royal Free Hospital, London, UK Invasive Aspergillosis 2 - Acquisition Preventive
More informationPulmonary Mucormycosis and Cytomegalovirus Co-Infection in a Renal Transplant Recipient
JOURNAL OF CASE REPORTS 2013;3(1):76-80 Pulmonary Mucormycosis and Cytomegalovirus Co-Infection in a Renal Transplant Recipient Gayathri Devi HJ, Mahesh E 1, Sulatha M Kamath 2, Jayanth K Das 3 From the
More informationHigh risk neutropenic patient (anticipated duration > 10 days) Send blood twice weekly for Beta -D Glucan Galactomanan Aspergillus PCR
DERBY TEACHING HOSPITALS NHS FOUNDATION TRUST Prophylaxis, diagnosis and treatment of invasive fungal infections in oncology/haematology patients with prolonged neutropenia. High risk neutropenic patient
More informationNeutropenic Sepsis Guideline
Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline - definitions Suspected or proven infection in a neutropenic patient is a MEDICAL EMERGENCY and is an indication for immediate assessment and prompt
More informationStudy of systemic fungal infections in renal transplant recipients
Original Research Article Study of systemic fungal infections in renal transplant recipients N.D. Srinivasaprasad 1*, G. Chandramohan 1, M. Edwin Fernando 2 1 DM (Nephrology), Assistant Professor, 2 DM
More informationCorrelation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02122.x Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis C. Cordonnier 1,
More informationAspergillosis in Pediatric Patients
Aspergillosis in Pediatric Patients Emmanuel Roilides, MD, PhD, FIDSA, FAAM 3rd Department of Pediatrics Aristotle University School of Medicine Thessaloniki, Greece 1 Transparency disclosures Independent
More informationSeptember 2014 Imaging Case of the Month. Michael B. Gotway, MD. Department of Radiology Mayo Clinic Arizona Scottsdale, AZ
September 2014 Imaging Case of the Month Michael B. Gotway, MD Department of Radiology Mayo Clinic Arizona Scottsdale, AZ Clinical History: A 57-year-old non-smoking woman presented to her physician as
More informationTherapy of Hematologic Malignancies Period at high risk of IFI
Therapy of Hematologic Malignancies Period at high risk of IFI Neutrophils (/mm 3 ) 5 Chemotherapy Conditioning Regimen HSCT Engraftment GVHD + Immunosuppressive Treatment Cutaneous and mucositis : - Direct
More informationCT-Guided Percutaneous Lung Biopsies in Patients With Suspicion for Infection May Yield Clinically Useful Information
Vascular and Interventional Radiology Original Research Haas et al. CT-Guided Percutaneous Lung Biopsies Vascular and Interventional Radiology Original Research Brian M. Haas 1 Joshua D. Clayton Brett
More informationEMA Pediatric Web Synopsis Protocol A November 2011 Final PFIZER INC.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationPneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)
Introduction Pneumocystis Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated
More informationShannon Carty, PGY-2 ICCR IRB Project Proposal April 9, 2008
Shannon Carty, PGY-2 ICCR IRB Project Proposal April 9, 2008 Study Title: Observational Study to Determine the Effect of an Emergency Department Adult Oncology Stat Antibiotic Protocol on Clinical Outcomes
More informationTrends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014
Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of
More informationAntimicrobial Management of Febrile Neutropenic Sepsis
Antimicrobial Management of Febrile Neutropenic Sepsis Written by: Dr J Joseph, Consultant Haematologist Dr K Gajee, Consultant Microbiologist Amended by: Larissa Claybourn, Antimicrobial Pharmacist Date:
More informationAntifungals and current treatment guidelines in pediatrics and neonatology
Dragana Janic Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic. University Children`s Hospital, Belgrade, Serbia 10/10/17 Hotel Crowne Plaza, Belgrade, Serbia; www.dtfd.org
More informationDIAGNOSTIC AND THERAPEUTIC THORACIC SURGERY IN LEUKEMIA AND SEVERE APLASTIC ANEMIA
DIAGNOSTIC AND THERAPEUTIC THORACIC SURGERY IN LEUKEMIA AND SEVERE APLASTIC ANEMIA James M. Habicht, MD a Alois Gratwohl b Michael Tamm, MD b Jfirgen Drewe, MD, PhD u Michael Proske, MD c Peter Stulz a
More informationImmune reconstitution Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
(2002) 30, 925 929 2002 Nature Publishing Group All rights reserved 0268 3369/02 $25.00 www.nature.com/bmt Immune reconstitution Aspergillus infections in allogeneic stem cell transplant recipients: have
More informationCryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More information